Vinva Investment Management Ltd Raises Holdings in Intuitive Surgical, Inc. $ISRG

Vinva Investment Management Ltd increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 105.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,363 shares of the medical equipment provider’s stock after acquiring an additional 9,925 shares during the period. Vinva Investment Management Ltd’s holdings in Intuitive Surgical were worth $8,505,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the stock. Parallel Advisors LLC grew its stake in shares of Intuitive Surgical by 1.1% during the 3rd quarter. Parallel Advisors LLC now owns 40,405 shares of the medical equipment provider’s stock worth $18,071,000 after purchasing an additional 452 shares during the period. Cladis Investment Advisory LLC acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $467,000. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund lifted its stake in shares of Intuitive Surgical by 18.2% in the 3rd quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund now owns 94,268 shares of the medical equipment provider’s stock valued at $42,159,000 after purchasing an additional 14,517 shares during the period. Rhenman & Partners Asset Management AB boosted its holdings in Intuitive Surgical by 9.4% during the third quarter. Rhenman & Partners Asset Management AB now owns 48,500 shares of the medical equipment provider’s stock worth $21,691,000 after buying an additional 4,150 shares in the last quarter. Finally, Grantham Mayo Van Otterloo & Co. LLC boosted its holdings in Intuitive Surgical by 4.6% during the third quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 1,139,659 shares of the medical equipment provider’s stock worth $509,690,000 after buying an additional 50,378 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Down 1.3%

Intuitive Surgical stock opened at $490.16 on Monday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $603.88. The firm has a market capitalization of $174.07 billion, a price-to-earnings ratio of 62.12, a PEG ratio of 3.78 and a beta of 1.66. The company has a fifty day simple moving average of $521.64 and a 200-day simple moving average of $512.51.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same period last year, the firm posted $2.21 earnings per share. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on ISRG. BTIG Research reaffirmed a “buy” rating and issued a $616.00 price objective on shares of Intuitive Surgical in a report on Friday, January 23rd. Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 19th. Sanford C. Bernstein raised their target price on Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a research report on Friday, January 23rd. Royal Bank Of Canada lifted their price target on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Wednesday, December 17th. Finally, HSBC upped their price target on Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a report on Monday, January 26th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $615.86.

Insider Buying and Selling

In other Intuitive Surgical news, Director Gary S. Guthart sold 2,800 shares of the firm’s stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $531.52, for a total value of $1,488,256.00. Following the transaction, the director directly owned 15,720 shares of the company’s stock, valued at $8,355,494.40. This trade represents a 15.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 421 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $208,378.16. Following the transaction, the executive vice president owned 409 shares in the company, valued at approximately $202,438.64. This represents a 50.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 37,261 shares of company stock worth $19,690,721 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.